Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1997 1
1998 1
1999 2
2000 1
2001 7
2002 7
2003 5
2004 7
2005 6
2006 9
2007 11
2008 16
2009 22
2010 23
2011 31
2012 24
2013 21
2014 27
2015 22
2016 27
2017 22
2018 18
2019 24
2020 31
2021 34
2022 31
2023 24
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

376 results

Results by year

Filters applied: . Clear all
Page 1
High levels of lipoprotein(a) in transgenic mice exacerbate atherosclerosis and promote vulnerable plaque features in a sex-specific manner.
Assini JM, Clark JR, Youssef A, Xing C, Doerfler AM, Park SH, Saxena L, Yaseen AB, Børen J, Gros R, Bao G, Lagor WR, Boffa MB, Koschinsky ML. Assini JM, et al. Among authors: doerfler am. Atherosclerosis. 2023 Nov;384:117150. doi: 10.1016/j.atherosclerosis.2023.05.019. Epub 2023 May 30. Atherosclerosis. 2023. PMID: 37290980
Prostate cancer in deceased organ donors: a review.
Doerfler A, Tillou X, Le Gal S, Desmonts A, Orczyk C, Bensadoun H. Doerfler A, et al. Transplant Rev (Orlando). 2014 Jan;28(1):1-5. doi: 10.1016/j.trre.2013.10.003. Epub 2013 Oct 24. Transplant Rev (Orlando). 2014. PMID: 24321301 Review.
LPA disruption with AAV-CRISPR potently lowers plasma apo(a) in transgenic mouse model: A proof-of-concept study.
Doerfler AM, Park SH, Assini JM, Youssef A, Saxena L, Yaseen AB, De Giorgi M, Chuecos M, Hurley AE, Li A, Marcovina SM, Bao G, Boffa MB, Koschinsky ML, Lagor WR. Doerfler AM, et al. Mol Ther Methods Clin Dev. 2022 Oct 13;27:337-351. doi: 10.1016/j.omtm.2022.10.009. eCollection 2022 Dec 8. Mol Ther Methods Clin Dev. 2022. PMID: 36381302 Free PMC article.
Germany's journey toward 14 Tesla human magnetic resonance.
Ladd ME, Quick HH, Speck O, Bock M, Doerfler A, Forsting M, Hennig J, Ittermann B, Möller HE, Nagel AM, Niendorf T, Remy S, Schaeffter T, Scheffler K, Schlemmer HP, Schmitter S, Schreiber L, Shah NJ, Stöcker T, Uder M, Villringer A, Weiskopf N, Zaiss M, Zaitsev M. Ladd ME, et al. Among authors: doerfler a. MAGMA. 2023 Apr;36(2):191-210. doi: 10.1007/s10334-023-01085-z. Epub 2023 Apr 8. MAGMA. 2023. PMID: 37029886 Free PMC article. Review.
Ischemia/reperfusion during normothermic perfusion.
Tillou X, Thuret R, Doerfler A; CTAFU. Tillou X, et al. Among authors: doerfler a. Prog Urol. 2014 Jun;24 Suppl 1:S51-5. doi: 10.1016/S1166-7087(14)70064-8. Prog Urol. 2014. PMID: 24950934 Review.
Prostate cancer before renal transplantation: A multicentre study.
Chahwan C, Doerfler A, Brichart N, Bouyé S, Culty T, Iselin C, Pfister C, Sallusto F, Salomon L, Verhoest G, Viart L, Tillou X; Renal Transplantation Committee of the French Urological Association (CTAFU). Chahwan C, et al. Among authors: doerfler a. Prog Urol. 2017 Mar;27(3):166-175. doi: 10.1016/j.purol.2017.01.001. Epub 2017 Feb 23. Prog Urol. 2017. PMID: 28237495
Les résultats de la néphrectomie partielle pour les carcinomes chromophobes du rein sont excellents. Étude rétrospective multicentrique à partir de 234 cas.
Bigot P, Bernhard J, Gill I, Vuong N, Verhoest G, Flammand V, Reix B, Suer E, Gökce I, Beauval J, Nouhaud F, Eto M, Baco E, Matsugasumi T, Chowaniec Y, Rigaud J, Lenormand C, Pfister C, Hetet J, Ploussard G, Roupret M, Léon P, El Bakri A, Larré S, Tillou X, Doerfler A, Descazeaud A. Bigot P, et al. Among authors: doerfler a. Prog Urol. 2015 Nov;25(13):800. doi: 10.1016/j.purol.2015.08.168. Prog Urol. 2015. PMID: 26544363 French. No abstract available.
Étude multicentrique sur les traitements conservateurs des tumeurs du greffon : vers les traitements ablatifs ?
Guleryuz K, Doerfler A, Bensadoun H, Boutin J, Bouyé S, Chambade D, Codas R, Coffin G, Devonec M, Erauso A, Hubert J, Karam G, Lechevallier E, Salomon L, Sénéchal C, Sallusto F, Terrier N, Timsit M, Thuret R, Verhoest G, Viart L, Tillou X. Guleryuz K, et al. Among authors: doerfler a. Prog Urol. 2015 Nov;25(13):766. doi: 10.1016/j.purol.2015.08.104. Prog Urol. 2015. PMID: 26544299 French. No abstract available.
Cancer de prostate en transplantation d'organes solides.
Tillou X, Guleryuz K, Le Gal S, Bouvier N, Chiche L, Bensadoun H, Doerfler A. Tillou X, et al. Among authors: doerfler a. Prog Urol. 2014 Nov;24(13):856. doi: 10.1016/j.purol.2014.08.162. Epub 2014 Oct 30. Prog Urol. 2014. PMID: 26461689 French. No abstract available.
Cancer de la prostate avant transplantation rénale : étude multicentrique.
Tillou X, Chahwan C, Brichart N, Bouyé S, Culty T, Pfister C, Salusto F, Salomon L, Verhoest G, Viart L, Doerfler A. Tillou X, et al. Among authors: doerfler a. Prog Urol. 2014 Nov;24(13):853. doi: 10.1016/j.purol.2014.08.155. Epub 2014 Oct 30. Prog Urol. 2014. PMID: 26461681 French. No abstract available.
376 results